To investigate whether quantitative liver-portal vein contrast ratio (Q-LPC) can be used as a substitute for quantitative liver-spleen contrast ratio (Q-LSC) in the hepatobiliary phase (HBP) contrasting degree. Q-LSC and Q-LPC were calculated in HBP images that were obtained approximately 20 min after gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid injection, and relationship between them was evaluated. A very strong correlation was observed between Q-LSC and Q-LPC with respect to Child-Pugh class. Furthermore, Q-LPC values were not significantly different between patients with splenectomy or Gamna-Gandy bodies and those without. Therefore, Q-LPC can be useful instead of Q-LSC in patients with splenectomy or Gamna-Gandy bodies.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinimag.2016.07.001DOI Listing

Publication Analysis

Top Keywords

gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic
8
penta-acetic acid
8
hepatobiliary phase
8
contrast ratio
8
q-lsc q-lpc
8
patients splenectomy
8
splenectomy gamna-gandy
8
gamna-gandy bodies
8
q-lpc
5
novel method
4

Similar Publications

Article Synopsis
  • The study aimed to evaluate the effectiveness of Sonazoid contrast-enhanced ultrasound (S-CEUS) and Gadolinium-Ethoxybenzyl-Diethylenetriamine Penta-Acetic Acid magnetic-resonance imaging (EOB-MRI) for diagnosing microvascular invasion (MVI) in hepatocellular carcinoma (HCC) before surgery.
  • Using data from 111 HCC cases, researchers analyzed various imaging indicators and clinical data to create a nomogram that predicts MVI risk, identifying key factors like tumor margins and capsule integrity.
  • The resulting MVI Nomogram showed high diagnostic accuracy, potentially enhancing preoperative assessments of MVI and improving treatment outcomes for HCC patients
View Article and Find Full Text PDF
Article Synopsis
  • Scientists are trying to make it easier and faster to find tumors in the liver (HCC) using new technology.
  • They developed a method that uses computer programs (deep learning) and help from doctors to automatically outline the tumors on MRI scans.
  • Their test showed that their new method is better at finding tumors than a doctor with moderate experience.
View Article and Find Full Text PDF

Comparison of computed tomography and magnetic resonance imaging findings and histopathological features of macrotrabecular-massive hepatocellular carcinoma.

Quant Imaging Med Surg

July 2023

Department of Hepatobiliary Surgery, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China.

Background: Macrotrabecular-massive hepatocellular carcinoma (MTM-HCC) is a novel subtype of HCC, one of eight distinct subtypes, that accounts for 5% of all cases of HCC and is associated with a worse prognosis. Preoperative diagnosis of MTM-HCCs using imaging findings can facilitate patient treatment decision-making. The purpose of this study was to describe computed tomography (CT) and magnetic resonance imaging (MRI) findings of MTM-HCCs and compare these findings with histopathological features.

View Article and Find Full Text PDF

Objectives: To evaluate the performance of a radiomics nomogram developed based on gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid (Gd-EOB-DTPA) MRI for preoperative prediction of microvascular invasion (MVI) of hepatocellular carcinoma (HCC), and to identify patients who may benefit from the postoperative adjuvant transarterial chemoembolization (PA-TACE).

Methods: A total of 260 eligible patients were retrospectively enrolled from three hospitals (140, 65, and 55 in training, standardized external, and non-standardized external validation cohort). Radiomics features and image characteristics were extracted from Gd-EOB-DTPA MRI image before hepatectomy for each lesion.

View Article and Find Full Text PDF

Background: Liver-spleen contrast in the hepatobiliary phase highly depends on the devices used for liver function tests. This study aimed to develop and validate a method to convert liver-spleen contrast data acquired with another device to reference liver-spleen contrast data, using the regression line of phantom contrasts (i.e.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!